Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and oleic acid

gadolinium dtpa has been researched along with oleic acid in 5 studies

Compound Research Comparison

Studies
(gadolinium dtpa)		Trials
(gadolinium dtpa)		Recent Studies (post-2010)
(gadolinium dtpa)		Studies
(oleic acid)		Trials
(oleic acid)		Recent Studies (post-2010) (oleic acid)
12,6546644,0518,7682483,051

Protein Interaction Comparison

ProteinTaxonomygadolinium dtpa (IC50)oleic acid (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)6.2

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsunaga, N; Ogasaware, N; Sasai, K; Suga, K1
Abendschein, DR; Chinen, LK; Fuhrhop, RW; Karukstis, KK; Lanza, GM; Scherrer, DE; Scott, MJ; Wickline, SA; Winter, PM; Yu, X1
Bulte, JW; Caruthers, SD; Chen, J; Gaffney, PJ; Lanza, GM; Miller, B; Robertson, JD; Song, SK; Wickline, SA; Winter, PM; Yu, X1
Cho, BM; Kim, HJ; Kim, YW; Lee, TH; Moon, TY; Park, BR; Pyeun, YS; Suh, KT1
Adam, G; Barch, M; Bawendi, MG; Bruns, OT; Chen, O; Chen, Y; Cordero, JM; Farrar, CT; Hansen, EC; Heine, M; Ittrich, H; Jasanoff, A; Kaul, MG; Li, N; Montana, DM; Nielsen, P; Okada, S; Wei, H; Wiśniowska, A1

Other Studies

5 other study(ies) available for gadolinium dtpa and oleic acid

ArticleYear
Perfusion characteristics of oleic acid--injured canine lung on Gd-DTPA--enhanced dynamic magnetic resonance imaging.
    Investigative radiology, 2001, Volume: 36, Issue:7

    Topics: Animals; Contrast Media; Disease Models, Animal; Dogs; Gadolinium DTPA; Image Enhancement; Lung; Lung Diseases; Magnetic Resonance Imaging; Oleic Acid; Posture; Pulmonary Circulation; Pulmonary Edema; Radiography; Regional Blood Flow

2001
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
    Circulation, 2002, Nov-26, Volume: 106, Issue:22

    Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Cell Membrane; Cells, Cultured; Contrast Media; Coronary Restenosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fluorine Compounds; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Oleic Acid; Oleic Acids; Paclitaxel; Particle Size; Swine; Thromboplastin

2002
Improved molecular imaging contrast agent for detection of human thrombus.
    Magnetic resonance in medicine, 2003, Volume: 50, Issue:2

    Topics: Contrast Media; Fibrin; Gadolinium DTPA; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Oleic Acid; Oleic Acids; Phosphatidylethanolamines; Thrombosis

2003
A model for research on the blood-brain barrier disruption induced by unsaturated fatty acid emulsion.
    Investigative radiology, 2005, Volume: 40, Issue:5

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Carotid Artery, Internal; Cats; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Emulsions; Gadolinium DTPA; Image Enhancement; Injections, Intra-Arterial; Linoleic Acid; Necrosis; Oleic Acid; Time Factors

2005
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 02-28, Volume: 114, Issue:9

    Topics: Albumins; Animals; Contrast Media; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Oleic Acid; Particle Size; Tissue Distribution

2017